Varian Eclipse Software Users Take Top Spots in Treatment Plan Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Jefferies Raises Price Target on Varian Medical Systems (VAR) to $98; Reiterates Buy
July 28, 2016 9:21 AM EDTJefferies reiterated a Buy rating on Varian Medical Systems (NYSE: VAR), and raised the price target to $98.00 (from $95.00), following the company's 3Q report.
Analyst Anthony Petrone commented, "VAR put up a $9mn/$0.05 beat highlighted by a surge in NA Oncology orders to +15% (from +7%).... More
